Drugs

Historical Information on REMS for Extended-Release and Long-Acting Opioid Drugs

This page includes background and historical information on the risk evaluation and mitigation strategy (REMS) for extended-release (ER) and long-acting (LA) opioid drugs. For additional information, please see REMS for Extended-Release and Long-Acting Opioids.

Page Last Updated: 10/20/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English